Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial-Reference-Cited by-同舟云学术

Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial

Published:2019-03 Issue: Volume:120 Page:137-140
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Miller P.D.,Hattersley G.,Lau E.,Fitzpatrick L.A.,Harris A.G.,Williams G.C.,Hu M.-Y.,Riis B.J.,Russo L.,Christiansen C.

Funder

Radius Health, Inc

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference14 articles.

1. Clinician's guide to prevention and treatment of osteoporosis;Cosman;Osteoporos. Int.,2014

2. Effects of abaloparatide-SC (BA058) on bone histology and histomorphometry: the ACTIVE phase 3 trial;Moreira;Bone,2017

3. Literature review: the effects of teriparatide therapy at the hip in patients with osteoporosis;Eriksen;Bone,2014

4. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use;Hodsman;Endocr. Rev.,2005

5. Timing of subsequent fractures after an initial fracture;van Geel;Curr. Osteoporos. Rep.,2010

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis;Journal of Bone and Mineral Metabolism;2024-07-15

2. Abaloparatid – eine neue osteoanabole Therapieoption für die Osteoporose bei postmenopausalen Frauen;Osteologie;2024-07-10

3. Effects of Abaloparatide on Bone Mineral Density in Proximal Femoral Regions Corresponding to Arthroplasty Gruen Zones;Journal of Bone and Joint Surgery;2024-05-01

4. A comprehensive review and advanced biomolecule-based therapies for osteoporosis;Journal of Advanced Research;2024-05

5. The Safety and Efficacy of Abaloparatide on Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis;Clinical Therapeutics;2024-03